AV1 (Viekira pak ombitasvir 12.5 mg / paritaprevir 75 mg / ritonavir 50 mg)
Generic Name: dasabuvir/ombitasvir/paritaprevir/ritonavir
Pill imprint AV1 has been identified as Viekira pak ombitasvir 12.5 mg / paritaprevir 75 mg / ritonavir 50 mg.
Viekira Pak is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Viekira Pak ombitasvir 12.5 mg / paritaprevir 75 mg / ritonavir 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- dasabuvir/ombitasvir/paritaprevir/ritonavir
- Imprint:
- AV1
- Strength:
- ombitasvir 12.5 mg / paritaprevir 75 mg / ritonavir 50 mg
- Color:
- Pink
- Shape:
- Rectangle
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- AbbVie Inc.
More about Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 8 Reviews – Add your own review/rating
- Drug class: antiviral combinations
Consumer resources
Other brands: Viekira XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
